Wire · operational-macro
Chinese Pharma Tech Exports Near 200 Trillion Won, Dwarfing South Korea
◆ Sectors
◆ Geography
◆ Source
◆ Verified
Fusion42 · 27 October 2026 · Fusion42 review
Chinese pharmaceutical and biotech companies are nearing 200 trillion Korean won in technology export contracts this year, vastly outpacing South Korea with nearly ten times the contract value. Large contracts and upfront payments are rising, signalling growing global influence, highlighted by major deals like CSPC Group's 18.5 billion-dollar contract with AstraZeneca.
This Wire brief sits within Fusion42's coverage of Health.
◆ ◆ The Wire takeaway
Chinese pharma firms have blown past South Korea in tech export deals, creating a gulf in global market power. You must rethink your regional partnerships and tech strategies to stay relevant in pharma innovation.
◆ Coverage
1 source · 27 Oct 2026
◆ Related on Wire
◆ Topics